BrieMika NoelChunMD

PubMed

• Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor.
  Duygu Altinok Dindar, Brie Chun, Amy Palma, John Cheney, Madeline Krieger, Kristin Kasschau, Keaton Stagaman, Zahi I Mitri, Shaun M Goodyear, Jackilen Shannon, Lisa Ka...> ;Nutrients. 2023 Oct 31
• A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
  David B Page, Joanna Pucilowska, Brie Chun, Isaac Kim, Katherine Sanchez, Nicole Moxon, Staci Mellinger, Yaping Wu, Yoshinobu Koguchi, Valerie Conrad, William L Redmon...> ;NPJ Breast Cancer. 2023 Jun 21
• 3 citations
  Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.
  Shaun M Goodyear, Evthokia A Hobbs, Andy Kaempf, Thomas Kartika, Jessica Ribkoff, Brie Chun, Zahi I Mitri, West, M. T., Malinda T West> ;The Oncologist. 2023 Aug 3
• 8 citations
  Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.
  Brie Chun, Joanna Pucilowska, ShuChing Chang, Isaac Kim, Benjamin Nikitin, Yoshinobu Koguchi, William L Redmond, Brady Bernard, Venkatesh Rajamanickam, Nathan Polaske,...> ;Journal for Immunotherapy of Cancer. 2022 Jan 1
• 28 citations
  Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
  Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L. Redmond, Walter J. Urba, Maritza Martel, Yaping Wu, Mary Campbell, Zhaoyu Sun, Gary L. Grunkemei...> ;Breast Cancer Research. 2021 Jan 7
• Join now to see all

Journal Articles

• Combination Immunotherapy strategies in breast cancer  
  Chun B, Page DB, McArthur HL, Current Breast Cancer Reports, 12/2019

Abstracts/Posters

• A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metast...
  Page DB, Kim IK, Chun B, Redmond WL, Martel M, Mori M, Wadell D, Moxon N, Mellinger SL, Urba WJ, Gucalp A, Traina TA, ASCO, Chicago IL, 5/2019
• First or second line pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC)
  Page DB, Chun B, Pucilowska J, Kim I, Sanchez K, Redmond WL, Sun Z, Wu Y, Feryn A, Martel M, Abaya CD, Wadell D, Mellinger S, Moxon N, Urba WJ, McAndrew P, El-Masry M,..., ASCO, Chicago, IL, 5/2019